Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
Clinical trial NCT00333060 · TERMINATED
Trial details
- NCT number
- NCT00333060
- Sponsor
- Othera Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.